Search This Blog

Tuesday, May 7, 2019

Eagle Pharmaceuticals sees FY19 R&D spending $32.0M-$36.0M

FY19 R&D spend compares to $38.0M in FY18. Sees FY19 SG&A on a non-GAAP basis, $51.0M-$54.0M, as compared to $43.0M in FY18.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)